MetaStat Inc
MTST
Rank in Stocks
#34822
MetaStat, Inc., a precision medicine company, focuses on discovering and... MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The companyโs therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
Share Price
$0.0007
Last synced: 2026-11-06
Market Cap
$4.11K
Change (1 day)
0.00%
Change (1 year)
133.33%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade MetaStat Inc (MTST)
Category
Industrials
Operating Margin for MetaStat Inc (MTST)
Operating Margin as of November 2026 TTM: -15,235.52%
According to MetaStat Inc's latest financial reports, its current operating margin (TTM) is -15,235.52%. At the end of 2018 the company had an operating margin of -15,235.52%.
Operating Margin history for MetaStat Inc from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -15,235.52% | 0.00% |
| 2018 | -15,235.52% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 16.36% | -100.00% |
CN
|
|
| 17.68% | -100.00% |
CH
|
|
| 17.68% | -100.00% |
IE
|
|
| 20.30% | -100.00% |
US
|
|
| 12.43% | -100.00% |
TH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about MetaStat Inc's operating margin
What is MetaStat Inc's operating margin?
MetaStat Inc's operating margin is -15,235.52%, as of Nov 2026.
What was MetaStat Inc's operating margin in 2018?
In 2018, MetaStat Inc's operating margin was -15,235.52%, compared with 0.00% in 2017.
How has MetaStat Inc's operating margin changed since 2013?
From 2013 to 2018, MetaStat Inc's operating margin was highest in 2017 (0.00%) and lowest in 2018 (-15,235.52%).
How does MetaStat Inc's operating margin compare with similar companies?
MetaStat Inc's operating margin (-15,235.52%) is lower than that of all 5 similar companies listed above. The highest among them is Vertiv Holdings Co, with 20.30%.